ICER
ICER
  • ICER Analytics™
  • Donate
  • Who We Are
    • History & Impact
    • People
    • Independent Funding
    • Frequently Asked Questions (FAQs)
  • Our Approach
    • Methods & Process
    • Policies
  • Engage with ICER
    • Patients
    • Clinicians
    • Manufacturers
    • Prospective Employees
    • Committees & Boards
  • News & Insights
    • Press Releases
    • Commentaries
    • Journal Articles
    • Weekly View
  • Explore Our Research
    • Assessments
    • Policy Papers
    • ICER Calendar
    • ICER ANALYTICS™
News & Insights / Journal Articles / Payer and Policy Maker Steps to Support Value-Based Pricing for Drugs

Payer and Policy Maker Steps to Support Value-Based Pricing for Drugs

Steve Pearson (President, ICER) and Peter Bach (Director, Center for Health Policy and Outcomes) have written a Viewpoint for the Journal of the American Medical Association looking at how payers and regulators can utilize value-based pricing methodologies for prescription drugs.

Back to Top
  • Contact
  • Careers
  • Find a Report
  • Donate
  • ICER ANALYTICS™ LOGIN

OUR NEWSLETTER.

A weekly digest of the top news
on ICER and US drug pricing. Sign Up


CONTACT US

Institute for Clinical and Economic Review
Two Liberty Square, Ninth Floor, Boston, MA 02109
Get Directions

+1 (617) 528-4013

Email: info@icer.org

Media Inquiries: mediainquiries@icer.org

ICER
© ICER, 2021
  • Terms and Conditions
  • Privacy Policy
Twitter Linkedin